• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar for Jan.28 - Feb. 1

 

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

FDA Official and Title Date Location Other FDA Participants Non-FDA Participants Subject
Andrew von Eschenbach, Commissioner, Food and Drugs 1/30/08 Rockville, MD Susan Winckler, Larry Bachorik, Kate Cook, Margaret Glavin, Randall Lutter, Pam Pisner, Jeff Senger, Mark Raza, Daniel  Schultz, Yolanda Jenkins William Hawkins, Peter Slone (Medtronic Inc,); Doug Badger (Nickles Group) Meet and greet with Medtronic's new President and CEO, William Hawkins
Andrew von Eschenbach, Commissioner, Food and Drugs 1/31/08 Rockville, MD Susan Winckler, Janet Woodcock, Norris Alderson, William Slikker, Larry Bachorik, Margaret Miller, Wanda Russ George Corcoran, Cheryl Walker, James Popp, Shawn Lamb (Society of Toxicology) To discuss ways to strengthen collaborations between FDA and Society of Toxicology
Andrew von Eschenbach, Commissioner, Food and Drugs 1/31/08 Rockville, MD Margaret Glavin, Jay Epstein, Mary Malarkey, Alan Williams, Mike Chappell, Evelyn Bonnin, Nancy Rose, Eric Blumberg, Larry Bachorik, Pam Pisner, Beth Clarke Mary Elcano, Eva Quinley, Kevin Brown, Chris Hrouda, Allan Goldberg, Sandy Belden, Sean McLaughin, Mark Weischedel (American Red Cross) Various issues
John Dyer, Deputy Commissioner for Operations and Chief Operating Officer 1/28/08 through 2/01/08 N/A N/A N/A No significant meetings
Murray Lumpkin, Deputy Commissioner for International and Special Programs 1/28/08 through 2/01/08 N/A N/A N/A No significant meetings
Randall Lutter, Deputy Commissioner for Policy 1/30/08 Westin Embassy Row Washington, DC Abby Jacobs, Frederico Goodsaid, Janet Woodcock, Mark Avigan, Nega Beru Registered Attendees The Toxicology Forum, 33rd Annual Winter Meeting/FDAAA
Janet Woodcock, Deputy Commissioner for Scientific and Medical Programs,  Chief Medical Officer and Acting Director, Center for Drug Evaluation and Research 1/28/08 Baltimore, MD Moheb Nasr Lawrence J. Delucas (U. of Alabama), Raymond Scherzer (GlaxoSmithKline), Ray Stark, Jennifer Homegran, Michelle Cohen (Honeywell) FDA's Critical Path Initiative
Janet Woodcock, Deputy Commissioner for Scientific and Medical Programs,  Chief Medical Officer and Acting Director, Center for Drug Evaluation and Research 1/30/08 Washington, DC Frederico Goodsaid, Abby Jacobs Keiji Yamamoto (Takeda Pharmaceutical Co.), Douglas Weed (The Weinberg Group), James McLeon (Scherring Plough) FDA's Commitment to Safety Biomarkers as New Tools to Improve the Drug Development Process
Janet Woodcock, Deputy Commissioner for Scientific and Medical Programs,  Chief Medical Officer and Acting Director, Center for Drug Evaluation and Research 2/2/08 Washington, DC N/A Mary McGuire Richards (Parkinson's Action Network) FDA Critical Path, Drug Development
Margaret Glavin, Associate Commissioner, Office of Regulatory Affairs 1/28/08 through 2/01/08 N/A N/A N/A No significant meetings
Jesse Goodman, Director, Center for Biologics Evaluation and Research 1/28/08 Washington, DC CBER, CDER and CDRH staff Representatives from industry and national and international organizations Well-Characterized Biotechnology Products Meeting - "CBER Update"
Daniel Schultz, Director, Center for Devices and Radiological Health 1/31/08 Rockville, MD Weinstein, Les S; Durfor, Charles; Tillman, Donna-Bea; Fischer, Ruth; Wolfhard, Vicky B; Ulatowski, Tim; Lenkel, Laurie; Chernaik, Beverly; Flamm, Eric; Raza, Mark; Gieser, Nancy; Thomas, Audrey A; McNamee, Scott, G.; Whitaker, Kathleen B; Lin, Chiu S.; Wolf, Deborah A.; Asher, David; Popek, Michael J.; Cook, Kate Ruey C. Dempsey, (AdvaMed); Robin Fatzinger, (Kensey Nash Corp.);Susan Gamble, (Edwards Lifesciences Corp); Ann Graves, (St. Jude Medical Inc.); Christine Loshbaugh,( Edwards Lifesciences Corp); Michael Morton, (Medtronic, Inc.); Dave Mueller, (St. Jude Medical Inc.); Ginny Weinknecht, Becton, Dickinson and Company (BD); Nancy Wooley, (ConvaTec Ltd.)  Proposed Rule BSE
Stephen Sundlof, Center for Food Safety and Applied Nutrition 2/1/08 White Oak, Bldg., Silver Spring, MD  David Acheson,   Tracey Summers Craig Henry, Ph.D.,  Senior Vice President, Jenny Scott, (Grocery Manufacturers Association)    FDA's  Food Protection Plan
Bernadette Dunham, Director, Center for Veterinary Medicine 1/31/08 Rockville, MD Steve Vaughn, Aila Albrecht Stephen Beinhoff, Gunther Schuele, Gary Bosch (Novartis) Courtesy Visit with Novartis
William Slikker, Director, National Center for Toxicological Research 1/29-30/08 Washington, DC Names not available Toxicology Researchers The 33rd Annual Winter Meeting of the Toxicology Forum
Gerald Masoudi, Chief Counsel 1/28/08 Rockville, MD Jarilyn Dupont, Michael Bernstein, Liz Jadove, Bill Frankos, Susan Bernard, Ann Wion, Louisa Nickerson, Kevin Fain Farah Ahmed, (Personal Care Products Council); Michael McGuffin, (AHPA); Andrew Shaw, Steve Mister, (Council for Responsible Nutrition); David Seckman, Daniel Fabricant,( Natural Products Association); David Spangler, (Consumer Healthcare Products Association) AER Labeling
Gerald Masoudi, Chief Counsel 1/31/08 New York City, NY N/A Members of NY State Bar Association's Food, Drug, and Cosmetic Law Section FDAAA Implementation: Reflections of the Chief Counsel